Original paper
Real-world incidence and cost of pneumonitis post-chemoradiotherapy for Stage III non-small-cell lung cancer
Abstract
Aim: To estimate the real-world incidence and timing of radiation pneumonitis following chemoradiotherapy for Stage III non-small-cell lung cancer and compare costs between patients with and without radiation pneumonitis. Methods: Retrospective analysis using the Symphony Health Integrated Dataverse. Results: Pneumonitis incidence was 12.4% with a 177-day mean time to onset. Patients with versus without pneumonitis were more frequently admitted...
Paper Details
Title
Real-world incidence and cost of pneumonitis post-chemoradiotherapy for Stage III non-small-cell lung cancer
Published Date
Jan 1, 2020
Journal
Volume
16
Issue
1
Pages
4303 - 4313
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History